Life enhancing drugs like growth hormone are prescribed for children who do not meet the FDA guidelines for therapy.

TOP INSIGHT
Educating the patients and maintaining proper electronic records for FDA guidelines may help in prescribing life enhancing drugs.
Kozlenkova, MSU assistant professor of marketing said, "Our research shows that not all consumers receive access to life-enhancing products; access depends on a complex combination of medical and non-medical factors related to the consumer, product and the physician."
"On the other hand, the effect of doctors approving consumer requests for prescriptions could also lead to overuse."
Life enhancing products are also found to be expensive which may create financial burdens on patients , insurance companies and tax payers.
The study investigated the medical and non-medical factors which trade offs doctors make regarding life-enhancing drugs and treatment was funded by the National Institute of Health. These products have a high value in the market and may include growth hormones, implants and stimulants.
About 656 pediatric endocrinologists were surveryed in the United States and doctors were asked to evaluate two groups. One group with slow growth and another group which was a bit faster.
"However, legally and practically, doctors have a lot of flexibility and discretion in their decisions." she said.
Research Findings:
- The study found that faster-growing children are also prescribed with drugs by doctors if their family requested.
- Untrained physicians tend to prescribe life enhancing drugs on request from child’s family
- Expensive drugs are less likely prescribed by the doctors.
The study concludes "Still, recognition of an inherent desire to do more -- especially for children -- is the first step toward any rational policy response"
Source-Medindia
MEDINDIA



Email





